[Form 4] CIMPRESS plc Insider Trading Activity

Rhea-AI Filing Summary

Cimpress plc (CMPR) — Form 4 insider sale: EVP & Chief Technology Officer Maarten Wensveen sold Cimpress ordinary shares on 11/03/2025. Reported sales were 21,010 shares at a weighted-average price of $68.24, 1,294 shares at $69.30, and 526 shares at $70.74. The prices reflect weighted averages within disclosed ranges. Following these transactions, he beneficially owned 20,587 shares, held directly.

The filing notes price ranges for each trade: $67.98–$68.97, $68.99–$69.95, and $70.02–$70.93, and states that detailed price-by-size information will be provided upon request.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wensveen Maarten

(Last) (First) (Middle)

CIMPRESS PLC, FIRST FLOOR BUILDING 3

FINNABAIR BUSINESS & TECHNOLOGY PARK

(Street)

DUNDALK, COUNTY LOUTH, IRELAND

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CIMPRESS plc [ CMPR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Chief Technology Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	11/03/2025		S		21,010	D	$68.24(1)	22,407	D
Ordinary Shares	11/03/2025		S		1,294	D	$69.3(2)	21,113	D
Ordinary Shares	11/03/2025		S		526	D	$70.74(3)	20,587	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects weighted-average sale price (per share prices actually received ranged from $67.98 to $68.97). Upon appropriate request, the reporting person will provide information regarding the number of shares sold at each price within the range.

2. Reflects weighted-average sale price (per share prices actually received ranged from $68.99 to $69.95). Upon appropriate request, the reporting person will provide information regarding the number of shares sold at each price within the range.

3. Reflects weighted-average sale price (per share prices actually received ranged from $70.02 to $70.93). Upon appropriate request, the reporting person will provide information regarding the number of shares sold at each price within the range.

Remarks:

	/s/ Matthew F. Walsh, as attorney-in-fact for Maarten Wensveen	11/05/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did CMPR disclose?

An officer sold Cimpress ordinary shares on 11/03/2025 and filed a Form 4 detailing the sales and post-trade holdings.

Who made the trades and what is their role at Cimpress (CMPR)?

Maarten Wensveen, Cimpress’s EVP & Chief Technology Officer, executed the reported sales.

How many CMPR shares were sold and at what prices?

21,010 shares at a weighted-average $68.24; 1,294 shares at $69.30; and 526 shares at $70.74.

What were the price ranges for the weighted-average trades?

Ranges were $67.98–$68.97, $68.99–$69.95, and $70.02–$70.93.

How many CMPR shares does the insider own after the transactions?

He beneficially owned 20,587 shares, held directly, after the reported trades.

Were any derivative securities involved?

No derivative securities were reported in the filing’s Table II.

Was the trading under a Rule 10b5-1 plan indicated?

The form includes a 10b5-1 checkbox, but the excerpt does not indicate it was selected.